Wild swings hit individual stocks as broader sector selloff spreads

The short version

This week delivered a split-screen market: while a broad consumer sector selloff dragged down major names, individual stocks posted dramatic single-session moves on company-specific catalysts.

The week opened with Silence Therapeutics more than doubling on Monday after Merck KGaA buyout news sent shares from $8.68 to $19.58, a 125.576% gain. On Tuesday, Braze Inc stock surged over 50% in a single session, climbing from $30.04 to $45.57.

Mid-week brought a different tone. AT&T shares tumbled 6.4% on Wednesday as the stock got swept up in a late-afternoon consumer sector selloff, falling from $23.42 to $21.91. The broader downdraft appeared to reflect sector-wide pressure rather than company-specific news.

Thursday saw Moderna shares crater 17% after cancer vaccine details leaked early, with the stock dropping from $245.81 to $202.63. The timing suggests the market reacted to information that may have been released ahead of schedule.

The week closed with another explosive move: AI OKTO stock nearly tripled on Friday after a surprise $3.50 dividend announcement, with shares jumping 182.8235% from $4.25 to $12.02 as traders piled in hours after the company’s announcement.

The pattern reveals two distinct market dynamics operating simultaneously. Mergers, dividend surprises, and product developments continued to drive outsized reactions in individual names, while sector-level forces pulled down even large-cap stocks like AT&T regardless of company fundamentals. The Moderna decline and the AT&T selloff both occurred within hours of their respective catalysts, suggesting rapid information processing by market participants.

This is explanatory coverage, not financial advice.